Amid Criticism, White House Says It Will Invest $2.7 Billion in Vaccine Production
Published
The money will go to firms doing business in the United States that make supplies necessary for vaccine production, including lipids, bioreactor bags, tubing, needles and syringes, officials said.
Full Article